Category Archives: Biochemistry

Penn State researchers awarded $2.86M to develop a new oral antibiotic to treat multidrug-resistant gonorrhea – Outbreak News Today

Up to $2.86Mhas been awardedto a research team including Penn State scientists to develop a new oral antibiotic to treat multidrug-resistant gonorrhea, a sexually transmitted disease caused by bacteria that have developed resistance to all but one existing antibiotic. The research team includes Penn State Professor of Biochemistry and Molecular Biology Kenneth Keiler, the U.S.-based clinical-stage biopharmaceutical companyMicrobiotix, as well as researchers from Emory University and the Uniformed Services University.

The funds are awarded by the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator,CARB-X, a non-profit partnership dedicated to accelerating early stage antibacterial research and development to address the rising global threat of drug-resistant bacteria. If the project successfully achieves certain development milestones, the team will be eligible for an additional $16 million in funding from CARB-X.

Drug-resistant gonorrhea is a growing global health problem that can cause serious and sometimes fatal health issues in men and woman and that has the possibility of increasing the risk of contracting or giving HIV, said Erin Duffy, chief of research and development at CARB-X, which is based at Boston University School of Law. Neisseria gonorrhoeae has developed resistance to the effects of antibiotics, and in some cases, there is only one drug to which the bacteria are susceptible.

The World Health Organization (WHO) estimates that about 78 million people a year are infected with gonorrhea; roughly 1.14 million of those infections occur in the U.S., of which an estimated 550,000 involve drug-resistant bacteria. Drug-resistant N. gonorrhoeae is identified by the WHO as a priority pathogen, and classified by the U.S. Centers for Disease Control and Prevention (CDC) as an urgent public health threat that requires aggressive action.

This project features a novel approach to creating a new antibiotic and is in the early stages of development, said Duffy. If successful and approved for use in patients, it could represent tremendous progress in the treatment of gonorrhea and help curb the spread of drug-resistant bacteria.

The research team will optimize and develop a series of compounds into a novel antibiotic that targets and inhibits an essential pathway for the bacteria to grow and replicatethe trans-translation pathway. This pathway rescues ribosomes that become trapped because of errors in protein synthesis.

80% of people carrying an STI may not show symptoms. Check for HIV, Chlamydia, Gonorrhea & Trich and other top risk STDs with our 100% confidential, fast at-home testing. Order now!

Because the trans-translation pathway is not found in animals, inhibiting the pathway should have a specific effect on bacteria and not host cells, said Keiler. This specificity makes inhibition of the trans-translation an attractive strategy for creating novel antibacterial agents.

Keiler discovered the trans-translation system as a graduate student, and his lab has studied the pathway over the last two decades. They have studied the biochemistry of the pathway and identified and characterized lead compounds for potential future drugs.

This grant is the culmination of a lab-to-clinic odyssey that started about 16 years ago with a seed grant from what is now the Penn State Huck Institutes of the Life Sciences and seed funding from the Eberly College of Science, said Keiler.

For this grant, Keilers lab will conduct biochemical experiments to test the activity of new compounds and microbiological characterization of the drugs, while Microbiotix and other collaborators will focus on drug formulation, animal studies, and, if successful, Phase I clinical trials in humans.

Proposed as a single dose oral therapy, this innovative program has great potential, not only to address the urgent threat posed by multidrug-resistant N. gonorrhoeae, but also to address other sexually-transmitted infection (STI) pathogens commonly found as coinfections, said Terry Bowlin, president & CEO of Microbiotix.

See the rest here:
Penn State researchers awarded $2.86M to develop a new oral antibiotic to treat multidrug-resistant gonorrhea - Outbreak News Today

Removing belly fat before it sticks to you – Science Codex

Triglycerides, those fats that seem to be the bane of any diet, remain a mystery for many researchers. Plenty of them are in Big Macs, deep pan pizza and the like, but some are a necessity to fuel the body for daily activities.

Researchers Mark Castleberry, a doctoral student, and professor Sean Davidson, both in the UC College of Medicine, have found a way to produce in the laboratory a human protein produced in the liver known as Apolipoprotein A5 (APOA 5). It plays an important role in metabolizing and clearing excess levels of triglycerides from the bloodstream.

Their findings are available in the American Society for Biochemistry and Molecular Biology's Journal of Lipid Research online. Castleberry, who is studying in the UC Department of Molecular Genetics, Biochemistry and Microbiology, is the paper's first author.

"We are really interested in understanding triglycerides because hypertriglyceridemia -- too much fat in your blood -- is a big factor leading to cardiovascular disease, diabetes, obesity and other health concerns," explains Davidson, who holds appointments in UC's departments of Pathology and Laboratory Medicine and Molecular Genetics, Biochemistry and Microbiology. "When you have a lot of fat that is hanging around in your circulation it's important to clear as much of it out as soon as possible."

"APOA5 is highly involved in how fast triglycerides get taken out of your circulation," says Davidson, who has a doctorate in biochemistry. "The more APOA5 you have the faster the triglyceride is removed. Everybody agrees it is an important protein but scientists don't know much about its structure or how it does what it does. If we could figure out how it works we could come up with a drug that uses the same mechanism or trigger it to work better."

The work demonstrates UC's commitment to research as described in its strategic direction called Next Lives Here.

Castleberry says researchers inserted a human gene coded by DNA into bacteria genetically engineered to produce human proteins. Once those proteins were produced they were removed from the host and purified for use in studies at the lab bench and in mouse models.

"We can quickly make a much greater amount of this protein using bacterial production than if we tried to isolate it from blood in humans," explains Castleberry. "The mice in this study were basically fed a large bowl of fat and triglycerides."

"We could analyze their blood after we fed them and observe the level of fat change as they digested the meal," said Castleberry. "We were able to give our protein to the mice that had that fatty meal and rapidly clear the triglycerides that would have accumulated in their blood."

See original here:
Removing belly fat before it sticks to you - Science Codex

Removing Belly Fat Before It Sticks to You: University Researchers Produce Fat-Busting Proteins – SciTechDaily

We are really interested in understanding triglycerides because hypertriglyceridemia too much fat in your blood is a big factor leading to cardiovascular disease, diabetes, obesity and other health concerns, explains Davidson, who holds appointments in UCs departments of Pathology and Laboratory Medicine and Molecular Genetics, Biochemistry and Microbiology. When you have a lot of fat that is hanging around in your circulation its important to clear as much of it out as soon as possible.

APOA5 is highly involved in how fast triglycerides get taken out of your circulation, says Davidson, who has a doctorate in biochemistry. The more APOA5 you have the faster the triglyceride is removed. Everybody agrees it is an important protein but scientists dont know much about its structure or how it does what it does. If we could figure out how it works we could come up with a drug that uses the same mechanism or trigger it to work better.

UC Professor Sean Davidson is shown with Mark Castleberry in a College of Medicine laboratory. Credit: Colleen Kelley/University of Cincinnati

The work demonstrates UCs commitment to research as described in its strategic direction called Next Lives Here.

Castleberry says researchers inserted a human gene coded by DNA into bacteria genetically engineered to produce human proteins. Once those proteins were produced they were removed from the host and purified for use in studies at the lab bench and in mouse models.

We can quickly make a much greater amount of this protein using bacterial production than if we tried to isolate it from blood in humans, explains Castleberry. The mice in this study were basically fed a large bowl of fat and triglycerides.

We could analyze their blood after we fed them and observe the level of fat change as they digested the meal, said Castleberry. We were able to give our protein to the mice that had that fatty meal and rapidly clear the triglycerides that would have accumulated in their blood.

Other co-authors of this study were Xenia Davis; Thomas Thompson, a professor in UCs Department of Molecular Genetics, Biochemistry and Microbiology, and Patrick Tso and Min Liu, both professors in UCs Department of Pathology and Laboratory Medicine.

Reference: Functional recombinant apolipoprotein A5 that is stable at high concentrations at physiological pH by Mark Castleberry, Xenia Davis, Min Liu, Thomas B. Thompson, Patrick Tso and W. Sean Davidson, 12 December 2019, Journal of Lipid Research.DOI: 10.1194/jlr.D119000103PDF

The research was supported by a National Institutes of Healths Heart, Lung and Blood Institute which funded a predoctoral fellowship for Castleberry.

See original here:
Removing Belly Fat Before It Sticks to You: University Researchers Produce Fat-Busting Proteins - SciTechDaily

Tel Aviv University joins volunteer initiative to improve detection of novel coronavirus in Israel – The Medical News

Reviewed by Emily Henderson, B.Sc.Mar 22 2020

Israeli hospitals and universities, including Tel Aviv University, have joined forces to build an enormous student volunteer base to expand and improve the detection of people infected with novel coronavirus all over Israel. In addition, TAU, together with the Weizmann Institute of Science and other institutes in Israel, has recruited over 600 doctoral students to volunteer their time and assist overburdened hospitals process coronavirus tests in laboratories.

The medical student initiative was launched by researchers and doctors at Chaim Sheba Medical Center, Hadassah Medical Center and Shamir Medical Center, together with the co-chairs of the Medical Students Association, which represents medical students at Israel's five universities.

The volunteer base is geared at scaling up Israel's capacity to conduct tests and produce critical coronavirus infection results more quickly. Accordingly, over 1,000 medical student volunteers from all over the country are helping Magen David Adom, Israel's National Pre-Hospital Medical and Blood Emergency Services Organization (MDA), collect test samples from people in communities across the country.

Dozens of volunteers have already joined MDA medics in collecting test samples this week, and some have even started to carry out the tests themselves."

Prof. Carmit Levy of the Department of Human Molecular Genetics and Biochemistry at TAU's Sackler Faculty of Medicine

This week, five doctoral students underwent coronavirus testing training, led by Prof. Ohad Gal-Mor of TAU's Sackler School of Medicine and the head of the Sheba Infectious Diseases Research Laboratory.

"It is inspiring to see students from all of the higher education institutions in the country enlisted bravely and resolutely to establish new laboratories and to assist existing laboratories in their efforts against the coronavirus," Prof. Levy adds.

The doctoral student volunteer mission was the brainchild of TAU, the Technion, Hebrew University, Bar-Ilan University, Ariel University and many medical centers, including Sheba, Shamir, Hadassah, Soroka, Wolfson, and Tel Aviv Sourasky Medical Center. Several HMOs are also taking part in this effort in full coordination with the Ministry of Health.

"The level of collaboration between faculty, physicians, health professionals and medical and graduate students at the universities, hospitals, HMOs, MDA, and Ministry of Health, is unprecedented in Israel," concludes Prof. Karen Avraham, Vice Dean of TAU's Sackler Faculty of Medicine. "This will set the stage for years to come for how much we can accomplish when working together so selflessly."

Read more:
Tel Aviv University joins volunteer initiative to improve detection of novel coronavirus in Israel - The Medical News

In vivo Comparison of the Biodistribution and Toxicity of InP/ZnS Quan | IJN – Dove Medical Press

Li Li,1,2 Yajing Chen,1 Gaixia Xu,2,3 Dongmeng Liu,1 Zhiwen Yang,1 Tingting Chen,1 Xiaomei Wang,1 Wenxiao Jiang,1 Dahui Xue,1 Guimiao Lin1

1Base for International Science and Technology Cooperation: Carson Cancer Stem Cell Vaccines R&D Center, Shenzhen Key Laboratory of Synthetic Biology, Department of Physiology, School of Basic Medical Sciences, Shenzhen University, Shenzhen 518055, Peoples Republic of China; 2Key Laboratory of Optoelectronics Devices and Systems of Ministry of Education/Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, Peoples Republic of China; 3Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Health Science Center, Shenzhen University, Shenzhen 518055, Peoples Republic of China

Correspondence: Guimiao LinSchool of Basic Medical Sciences, Shenzhen University Health Sciences Center, Shenzhen 518060, Peoples Republic of ChinaTel/ Fax +86-755-86671903Email gmlin@szu.edu.cn

Introduction: Indium phosphide (InP) quantum dots (QDs) have shown a broad application prospect in the fields of biophotonics and nanomedicine. However, the potential toxicity of InP QDs has not been systematically evaluated. In particular, the effects of different surface modifications on the biodistribution and toxicity of InP QDs are still unknown, which hinders their further developments. The present study aims to investigate the biodistribution and in vivo toxicity of InP/ZnS QDs.Methods: Three kinds of InP/ZnS QDs with different surface modifications, hQDs (QDs-OH), aQDs (QDs-NH2), and cQDs (QDs-COOH) were intravenously injected into BALB/c mice at the dosage of 2.5 mg/kg BW or 25 mg/kg BW, respectively. Biodistribution of three QDs was determined through cryosection fluorescence microscopy and ICP-MS analysis. The subsequent effects of InP/ZnS QDs on histopathology, hematology and blood biochemistry were evaluated at 1, 3, 7, 14 and 28 days post-injection.Results: These types of InP/ZnS QDs were rapidly distributed in the major organs of mice, mainly in the liver and spleen, and lasted for 28 days. No abnormal behavior, weight change or organ index were observed during the whole observation period, except that 2 mice died on Day 1 after 25 mg/kg BW hQDs treatment. The results of H&E staining showed that no obvious histopathological abnormalities were observed in the main organs (including heart, liver, spleen, lung, kidney, and brain) of all mice injected with different surface-functionalized QDs. Low concentration exposure of three QDs hardly caused obvious toxicity, while high concentration exposure of the three QDs could cause some changes in hematological parameters or biochemical parameters related to liver function or cardiac function. More attention needs to be paid on cQDs as high-dose exposure of cQDs induced death, acute inflammatory reaction and slight changes in liver function in mice.Conclusion: The surface modification and exposure dose can influence the biological behavior and in vivo toxicity of QDs. The surface chemistry should be fully considered in the design of InP-based QDs for their biomedical applications.

Keywords: InP/ZnS quantum dots, surface chemistry, in vivo, biodistribution, nanotoxicology

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

View post:
In vivo Comparison of the Biodistribution and Toxicity of InP/ZnS Quan | IJN - Dove Medical Press

Hero Proteins May Shield Other Proteins from Harm – The Scientist

Researchers at RIKEN and the University of Tokyo report the existence of a new class of proteins in Drosophila and human cell extracts that may serve as shields that protect other proteins from becoming damaged and causing disease. An excess of the proteins, known as Hero proteins, was associated with a 30 percent increase in the lifespan of Drosophila, according to the study, which was published last week (March 12) in PLOS Biology.

The discovery of Hero proteins has far-reaching implications, says Caitlin Davis, a chemist at Yale University who was not involved in the study, and should be considered both at a basic science level in biochemistry assays and for applications as a potential stabilizer in protein-based pharmaceuticals.

Nearly 10 years ago, Shintaro Iwasaki, then a graduate student studying biochemistry at the University of Tokyo, discovered a strangely heat-resistant protein in Drosophila that seemed to help stabilize another protein, Argonaute, in the face of high temperatures that would denature most proteins. Although he didnt publish the work at the time, Iwasaki called the new type of protein a Heat-resistant obscure (Hero) proteinnot because of their ability to rescue Argonaute from destruction, but because in Japan, the term hero means weak or not rigid, and Hero proteins dont have stiff 3-D structures like other proteins do. But recognition of a more widespread role for Hero proteins in protecting other molecules in the cell gives the name new meaning.

It is generally assumed that proteins are folded into three-dimensional structures, which determine their functions, says Kotaro Tsuboyama, a biochemist at the University of Tokyo and the lead author of the new study. But these 3-D structures are disrupted when the proteins are exposed to extreme conditions. When proteins are denatured, they lose the ability to function normally, and sometimes begin to aggregate, forming pathologic clumps that can lead to disease.

Hero proteins can survive these biologically challenging conditions. Heat-resistant proteins have been found in extremophilesorganisms known to live in extreme environmentsbut were thought to be rare in other organisms. In the new study, Tsuboyama and his team boiled lysates from Drosophila and human cell lines, identifying hundreds of Hero proteins that withstood the temperature.

The researchers selected six of these proteins and mixed them with client proteinsother functional proteins that on their own would be denatured by extreme conditionsbefore exposing them to high temperatures, drying, chemicals, and other harsh treatments. The Hero proteins prevented certain clients from losing their shape and function.

Next, the team tested the effects of Hero proteins in cellular models of two neurodegenerative disorders characterized by pathologic protein clumps: Huntingtons disease and amyotrophic lateral sclerosis (ALS). When the Hero proteins were present, there was a significant reduction in protein clumping in both models.

This is an extremely important finding as it may pave new therapeutic and preventive strategies for neurodegenerative diseases, such as Alzheimer and Parkinson diseases, Morteza Mahmoudi, who studies regenerative medicine at Michigan State University and was not involved in the research, writes in an email to The Scientist.

Lastly, the team genetically engineered Drosophila to produce an excess of Hero proteins. These flies lived up to 30 percent longer than their wildtype counterparts.

Not everyone is convinced that the Hero proteins play a major protective role. Although they show these proteins help their proven targets remain folded/shielded etc, I dont think theres a broader application at all, Nihal Korkmaz, who designs proteins at the University of Washington Institute of Protein Design and also did not participate in the study, tells The Scientist in an email. She adds that many proteins she works with can withstand high temperatures and the researchers dont mention at all if [Hero proteins] are found throughout the brain or in CSF [cerebrospinal fluid], where theyd be able to protect against Huntingtons or ALS.

The authors emphasized that there is a lot left to learn about the proteins. Each Hero protein seems able to protect some client proteins, but not all of them. Moreover, amino acid sequences differ considerably between Hero proteins, making it difficult to predict their functions. The researchers write in the study that they hope future studies will help them identify which clients each Hero might work with.

Whatever discoveries future work might hold, Tsuboyama says, the scientific communitys reaction to the teams new study has been consistent: Almost everyone says that Hero proteins are interesting but mysterious.

K. Tsuboyama et al., A widespread family of heat-resistant obscure (Hero) proteins protect against protein instability and aggregation,PLOS Biol,doi:10.1371/journal.pbio.3000632, 2020.

Emma Yasinski is a Florida-based freelance reporter. Follow her on Twitter@EmmaYas24.

Go here to read the rest:
Hero Proteins May Shield Other Proteins from Harm - The Scientist

The Applications and Advantages of HILIC – AZoM

Image Credit:Gorodenkoff/Shutterstock.com

Liquid chromatography is an analytical technique used to separate components in a mixture using a liquid mobile phase and solid stationary phase. The mode of chromatography used depends on the polarity of the analyte of interest.

Two of the most common types of liquid chromatography include normal phase and reversed-phase chromatography, but now hydrophilic interaction chromatography (HILIC), which is a mixed-mode of chromatography, has gained popularity, showing many advantages over the more traditionally used liquid chromatography techniques.

Hydrophilic interaction chromatography is a type of mixed-mode liquid chromatography, mainly used for the separation of polar compounds.

When HILIC first appeared, it was considered a new type of normal phase chromatography, however, now it is thought to be much more complex than being just another type of normal phase chromatography. HILIC does use polar stationary phases that are used in normal phase chromatography, but the mobile phase used is like that in reversed-phase chromatography.

Like other modes of chromatography, HILIC has a range of different stationary phases available, including silica-based, pentafluorophenyl and pentahydroxy phase columns. The mobile phase for HILIC is generally acetonitrile with a small percentage of water, although other solvents that are miscible with water, such as THF, can also be used. Using acetonitrile as a solvent means that the lipid bilayer inside the column does not get disrupted as it would potentially be if an alcohol mobile phase was used. Additives in the mobile phase such as ammonium acetate and ammonium formate can be added to control the pH and ionic strength.

The mode to which HILIC works is not fully understood, but it is thought to work by the polar analytes partitioning in and out of the water layer that is adsorbed onto the stationary phase surface. Dipole electrostatic interactions are also thought to play a part in how HILIC works.

There are many advantages of HILIC over other kinds of chromatography. These include:

There are not many disadvantages to using HILIC over other types of chromatography if HILIC suits the compound of interest, but there are some disadvantages to consider. These include:

HILIC can be used across a wide range of fields to analyze polar chemical and biochemical molecules. Fields that HILIC is used include pharmacology, biochemistry, the food industry and in agriculture.

The most common area of analysis is for drugs and their metabolites, but HILIC is also being used to analyze carbohydrates, peptides, antibiotics and pesticides. The use of HILIC to analyze biological samples has increased because sample preparation when looking for metabolites is very simple, as metabolic processes uses the addition of polar groups.

The applications of HILIC across each field include:

Buszewski, B. and Noga, S. (2011). Hydrophilic interaction liquid chromatography (HILIC)a powerful separation technique. Analytical and Bioanalytical Chemistry, 402(1), pp.231-247.

Heaton, James & Smith, Norman. (2012). Advantages and Disadvantages of HILIC; a Brief Overview. Chromatography Today. 5. 44-47.

Rodrguez-Gonzalo, E. and Garca-Gmez, D. (2018). Hydrophilic Interaction Chromatography: Current Trends and Applications. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.

https://www.news-medical.net/life-sciences/Hydrophilic-Interaction-Chromatography-Applications.aspx

https://www.chromacademy.com/

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

See more here:
The Applications and Advantages of HILIC - AZoM

New Details Revealed on How Plants Maintain a Healthy Sperm-Egg Ratio – UMass News and Media Relations

AMHERST, Mass. Current molecular biochemistry, microscopy and genetic techniques have become so powerful that scientists can now make mechanistic discoveries supported by multiple lines of evidence about intimate processes in plant reproduction that once were very difficult to examine, says molecular biologist Alice Cheung at the University of Massachusetts Amherst.

She is the senior author of a new paper in Nature describing how she and her team used such tools to solve, in unprecedented detail, the mechanisms of how flowering plants avoid polyspermy. As the name suggests, polyspermy results from multiple sperm entering and fertilizing an egg, a condition harmful to the zygote. In plants, preventing polyspermy also means higher chances for more females to be fertilized and ensures better seed yields, both of which are agriculturally important, Cheung points out.

For years, she and her long-time collaborator Hen-Ming Wu have led a team that includes a former postdoctoral associate, Qiaohong Duan, a current postdoc Ming-Che (James) Liu, and several graduate students in investigating FERONIAs dual roles in reproduction. For the current paper Duan and Liu are co-first authors.

Cheung says, It is very exciting to be able to explain how in multiple steps a plant creates an environment in its ovule, where the egg cell is located, that is first receptive to an incoming pollen tube to deliver sperm, but once fertilization is ensured it will instantly switch to block more pollen tubes from approaching to guard against polyspermy. These two acts are controlled by a gene called FERONIA, she adds, which encodes the FERONIA receptor kinase that senses signals on the cell surface and instructs the cell to respond appropriately.

Cheung says one of the key discoveries in their latest work is FERONIAs role in the cell wall and, in particular, its ability to interact with pectin, a sugar polymer in the wall. As conditions vary, one form of this polymer, called de-esterified pectin, can maintain a malleable wall, for example, so the first pollen tube arriving at the egg chamber inside the ovule can penetrate. But this pectin can also abruptly harden after the first pollen tube has penetrated, blocking more from entering.

This special pectin also triggers other activity, they discovered. Cheung and colleagues say they observed for the first time that de-esterified pectin serves as a signal to trigger an environment enriched in nitric oxide (NO) at the entrance to the egg chamber. In a series of bioassays, molecular interaction and biochemical analyses, they show that this gaseous signaling molecule modifies and de-activates a chemoattractant produced by the female to guide pollen tubes to their target. This quick change insures that late-arriving pollen tubes cannot approach an already fertilized ovule.

Cheung explains, As a gas, NO can diffuse very quickly, maybe even instantly as it is produced. The title of our paper, FERONIA controls pectin- and nitric oxide-mediated male-female interaction captures how our latest work connects these two FERONIA- controlled conditions. What led us to our findings is that without FERONIA, the cell wall is deficient in de-esterified pectin, but with FERONIA present, the wall works both as a source of signal molecules to trigger NO and also a physical barrier.

The molecular biologist says that because of its almost global importance to plant survival that her group and others have demonstrated, there are now likely dozens of labs around the world from plant stress physiologists to molecular structural biologists pursuing different aspects of FERONIA and its related proteins. Cheung says some of these proteins function together in very intriguing ways, so there is immense potential for advances in plant biology and fundamental signal transduction mechanisms from this very active field.

Go here to read the rest:
New Details Revealed on How Plants Maintain a Healthy Sperm-Egg Ratio - UMass News and Media Relations

NMMTA sceptical of MoH&FWs new gazette on the requirement of PhD for authorised signatory at diagnostic labs – Express Healthcare

The National MSc Medical Teachers Association (NMMTA) recently wrote to the Ministry of Health and Family Welfare sharing their reservations related to the recent gazetted notification by the ministry on the compulsion of PhD degree for authorisation of lab reports at all medium and advanced laboratories.

According to the latest gazette notification regarding Clinical Establishment (Central Government) Amendment Rules 2020, professionals with MSc degree in medical microbiology or medical biochemistry with three years of laboratory experience can become authorised signatory in a diagnostic laboratory for tests respective to their specialisation without recording any opinion or interpretation of lab results.

A PhD in medical microbiology or medical biochemistry shall be required for medium and advanced laboratories, the gazette stated. The notification came after the Board of Governors of the Medical Council of India (MCI) communicated its decision regarding the role of an authorised signatory to the ministry.

In keeping with this, the NMMTA had filed a writ petition in Delhi High Court in 2019, and hearing of the case was supposed to take place on 16th March, 2020 but due to the outbreak of novel Covid-19, it has been postponed to 20th May, 2020.

Commenting on the recent announcement and due next course of actions, Dr Sridhar Rao, President, National MSc Medical Teachers Association said, We welcome the initiated move by MoHFW, but we do have some reservations on this. We believe that knowledge and skills required to interpret and sign diagnosis test reports, are already acquired during the Medical MSc. Postgraduate course and PhD degree dont confer any additional skills or knowledge in performing these routine tests. And to highlight this aspect, we have already written a letter to the ministry.

He also pointed out that since the medical laboratory sector does not have the streamlined regulatory system/agency to provide the exact numbers, our crude estimation is that there would be approximately 30,000 qualified professionals, who will be deprived or demotivated from their work. In such a condition, where we have lakhs of laboratories across the country, and knowing the fact of scarcity of qualified doctors in the country, will it be possible for doctors to sign the reports instead of attending patients? Understanding the situation, we recommend to the ministry that the scientists with appropriate qualifications and training, who are already available, government should utilise their services rather than siding them away.

Clinical scientists signing laboratory reports is practised all over the world, including the US, the UK, the European Union, Middle East countries, New Zealand, Sri Lanka, Nepal, etc. In fact, the West Bengal government had included the clinical scientists in its Clinical Establishments Act guidelines. With the Union government clearing the way, rest of the states must adopt these guidelines. However, we have already asked all the state government health officials to implement the amendment as per the latest gazette notification regarding Clinical Establishment (Central Government) Amendment Rules 2020, he added.

[emailprotected]

Visit link:
NMMTA sceptical of MoH&FWs new gazette on the requirement of PhD for authorised signatory at diagnostic labs - Express Healthcare